Health

FDA Grants Breakthrough Therapy Designation to Huahui Health's Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection

BEIJING, Nov. 18, 2024 /PRNewswire/ -- Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, and oncology, today announced that its investigational hepatitis D and B drug candidate, Libevitug (HH-00...

2024-11-18 18:40 942

Perennial Alzheimer's Care Village Xi'an Positioned as China's First and the World's Sixth Alzheimer's Care Village

Integrated Western and Eastern medicine, coupled with non-drug intervention therapies, sets international standards for Alzheimer's care inChina SINGAPORE, Nov. 18, 2024 /PRNewswire/ -- Perennial Holdings Private Limited (" Perennial Holdings") is pleased that Perennial Alzheimer's Care Village ("...

2024-11-18 18:31 3832

New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence

New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON, Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership withHealthcare Executi...

2024-11-18 16:00 1160

SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors

TEL AVIV, Israel, Nov. 18, 2024 /PRNewswire/ -- SoniVie Ltd. , a medical device company developing a proprietary renal denervation system to treat hypertension, announced today the appointment ofRaymond W. Cohen to serve as its chairman of the board of directors. Mr. Coh...

2024-11-18 09:00 825

Boehringer Ingelheim Commits to Veeva Vault CRM

Top biopharma company selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches SINGAPORE, Nov. 18, 2024 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Boehringer Ingelheim is the latest global to...

2024-11-18 09:00 1117

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

* Single dose of RN0191 achieved up to 95% individual maximum and 87% mean maximum PCSK9 reduction, and up to 74% individual maximum and 56% mean maximal LDL-C lowering * Robust and sustainable treatment effects support at least bi-annual dosing regimen * Best-in-class potential of novel PC...

2024-11-18 09:00 1688

SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors

TEL AVIV, Israel, Nov. 14, 2024 /PRNewswire/ -- SoniVie Ltd. , a medical device company developing a proprietary renal denervation system to treat hypertension, announced today the appointment ofRaymond W. Cohen to serve as its chairman of the board of directors. Mr. Coh...

2024-11-18 08:00 776

Sky Labs' Wearable Device "Apollon" Recognized as an Honoree in CES 2025 Innovation Awards

SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ -- Sky Labs announced that its groundbreaking wearable device,Apollon, has been named an "Honoree" in the Artificial Intelligence category at the CES 2025 Innovation Awards. Hosted by the Consumer Technology Association (CTA)®, the CES Innovation Awa...

2024-11-18 08:00 1136

Getz Healthcare and IGEA Medical Announce Strategic Distribution Agreement to Introduce Adaptive Electroporation Technologies in Australia

This partnership aims to provide a new frontier in cancer care and vascular malformation treatment, offering clinicians cutting-edge technology to improve patient outcomes. SYDNEY, Nov. 18, 2024 /PRNewswire/ -- Getz Healthcare Australia is proud to announce a strategic distribution agreemen...

2024-11-18 07:30 943

1st MINISH Academy for Japanese dentists to be held in Korea

TOKYO and SEOUL, South Korea, Nov. 18, 2024 /PRNewswire/ -- On the 18th, MINISH Technology Inc. announced it will host a "Special Course for Japanese Dentists" at MINISH Dental Hospital in Gangnam,Seoul, from November 28 to 30. At MINISH Academy...

2024-11-18 05:00 974

Ascentage Pharma Announces a New Drug Application for Its Novel Bcl-2 Inhibitor Lisaftoclax Accepted and Recommended Priority Review Designation by CDE of China NMPA

ROCKVILLE, Md. and SUZHOU, China, Nov. 17, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that a New Drug Applica...

2024-11-17 22:24 1448

DermRays Black Friday Event Offers Year's Biggest Savings and Industry Recognition

PLEASANTON, Calif., Nov. 16, 2024 /PRNewswire/ -- This Black Friday, DermRays is excited to announce its most significant sale of the year, offering$130 off sitewide fromNovember 16-30th, 2024. With this limited-time discount, customers can experience the brand's advanced home laser hair removal ...

2024-11-16 21:00 1085

World-Class Scientists Gather at Tencent 2024 WE Summit in Chengdu to Share Cutting-Edge Discoveries

Five eminent speakers, including Nobel laureates and the top Chinese physicist Qi-Kun Xue, share groundbreaking insights at theTencent WE Summit in Chengdu. SHENZHEN, China, Nov. 15, 2024 /PRNewswire/ -- On November 3, the 12th Annual Tencent WE Summit took place at the Chengdu Science Fiction Mu...

2024-11-15 22:59 2436

World-Class Scientists Gather at Tencent 2024 WE Summit in Chengdu to Share Cutting-Edge Discoveries

Five eminent speakers, including Nobel laureates and the top Chinese physicist Qi-Kun Xue, share groundbreaking insights at theTencent WE Summit in Chengdu. SHENZHEN, China, Nov. 15, 2024 /PRNewswire/ -- On November 3, the 12th Annual Tencent WE Summit took place at the Chengdu Science Fiction Mu...

2024-11-15 22:57 1678

Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth

- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology and Company Leadership - Aims to Strategically Expand Business and Management Functions for Establishing a Strong Presence in Global Markets SEOUL, South Korea, Nov. 15, 2024 /PRNewswire/ -- Neuroph...

2024-11-15 22:00 1484

Angel Yeast Turns Automation into Opportunity, Ensuring No Job Losses

YICHANG, China, Nov. 15, 2024 /PRNewswire/ -- Angel Yeast has taken a significant step towards modernization and sustainability by automating its packaging line while ensuring no layoffs for its employees. In 2024, with the completion of the intelligent transformation of its packaging workshop, t...

2024-11-15 20:00 1187

Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in IgG4-Related Disease

* IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program  * ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) * The planned clinical ...

2024-11-15 20:00 1203

Nuvilab: Advancing School Nutrition with AI-Powered Nutrition Coaching, Wins CES 2025 Innovation Award

SEOUL, South Korea, Nov. 15, 2024 /PRNewswire/ -- Nuvilab announced that its innovative AI nutrition coaching solution,NutriTrex, was awarded the CES 2025 Innovation Award in the Digital Health category. This prestigious honor highlights Nuvilab's groundbreaking approach to promoting healthy eati...

2024-11-15 18:31 1270

Ping An Health Launches "Healthy Steps" Initiative to Boost National Health Literacy Through Collaboration

HONG KONG and SHANGHAI, Nov. 14, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) launched the "Healthy Steps" National Health Literacy Initiative at the Ping An Finance Center inShanghai. This ...

2024-11-15 11:00 1351

Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 14, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...

2024-11-15 09:55 1145
1234567 ... 860